MINNEAPOLIS, Jan. 30, 2014 /PRNewswire/ -- Skyline Medical (OTCQB: SKLN) is making it easier for hospitals and surgery centers to include state-of-the-art waste management systems in new and renovated facilities. The company is making its revolutionary, FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal available through Attainia software — the world's most widely used healthcare equipment planning and budgeting software.
"Our partnership with Attainia will increase awareness among healthcare organizations worldwide that they have an alternative to the antiquated, high-risk fluid disposal methods they've been using for years," said Josh Kornberg, CEO of Skyline Medical, formerly BioDrain Medical. "The patented STREAMWAY System is the first truly closed system designed specifically for medical applications, where safety simply cannot be compromised. Our system is a one-piece, wall-mounted unit that connects directly to a facility's plumbing system to minimize human intervention, provide unlimited capacity, and eliminate the cost and environmental waste of canisters," Kornberg explained. "By working closely with clinical teams and architect partners in the early stages, we can ensure a seamless and successful installation."
Skyline Medical chose Attainia because it's the industry leader in healthcare equipment planning. "Currently, more than 2,000 active healthcare projects are being planned using Attainia software systems, totaling more than $30 billion," Kornberg said. "As a leading provider for healthcare planning, Attainia was a logical choice for our new alternative solution to fluid waste management."
"Attainia's purpose is to give healthcare organizations access to all the latest technologies and equipment as they plan their facilities," said Attainia Vice President of Supply Chain Services Anil Singhal, MD. "Skyline's STREAMWAY System is a new disruptive technology that gives our customers a new choice in the critical fluid waste management function."
The STREAMWAY System will debut in the Attainia catalog in mid-February under two Fluid Waste Management categories — Surgical Fluid Collection and Surgical Fluid Disposal — since the single automated system covers both functions. The STREAMWAY System is used in operating rooms, as well endoscopy, radiology and other specialty departments.
About Skyline Medical Inc.
Skyline Medical Inc. produces a fully automated, patented, FDA-cleared, waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods — which require hand carrying and emptying filled fluid canisters — present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers, 2) improve compliance with Occupational State and Health Association (OSHA) and other regulatory agency safety guidelines, 3) improve efficiency in the operating room, and radiology and endoscopy departments — leading to greater profitability, and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United States. For additional information, please visit: www.skylinemedical.com.
Attainia provides innovative solutions to managing the complex capital equipment lifecycle. Its systems are the world's most widely used healthcare planning and budgeting applications. Customers include some of the largest healthcare architectural and planning firms, as well as healthcare integrated delivery networks and individual hospitals. Subscribers engage in all phases of cloud-based project planning and budgeting with access to Attainia's comprehensive catalog of manufacturers, products and solutions at www.attainia.com.
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, inability to raise sufficient additional capital to operate our business; approximately $2.7 million in debts, liabilities and cash obligations that become due over the next twelve months; unexpected costs and operating deficits, and lower than expected sales and revenues, if any; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; and inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the Company's most recent Annual Report on Form 10-K, as amended, and subsequent 8-K and other filings at www.sec.gov.
Skyline Investor Relations Contacts:
Todd Fromer / Phil Carlson
KCSA Strategic Communications
212-896-1215 / 212-896-1233
+1 866 288 2464 ext 712
SOURCE Skyline Medical